Jinan Shamou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jinan Shamou has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Laila Layqah
King Saud bin Abdul-Aziz University for Health Sciences, Riyadh, Saudi Arabia; Research office, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
2 shared publications - Abbas Al Mutair
Research Center, Almoosa Health Group, Al-Ahsa, Saudi Arabia
1 shared publication Abdulaziz Boqaeid
Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
1 shared publication- Abdulaziz M. Alsedrah
College of Pharmacy, King Saud University, Riyadh 11426, Saudi Arabia
1 shared publication - Abdullah Al-Roqy
Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia
1 shared publication Abdullah Alsaeedi
Department of Medicine, Al-Jahra Hospital, Kuwait
1 shared publication
Latest Publications
- Open Access
- 21 April 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (6) , 1134-1141
The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy
- 21 April 2024
- Published by Elsevier in Journal of Infection and Public Health
- Vol. 17 (6) , 1134-1141
Open AccessThe risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy
- Open Access
Clinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
Background: Acute Respiratory Distress Syndrome (ARDS) is caused by non-cardiogenic pulmonary edema and occurs in critically ill patients. It is one of the fatal complications observed among severe COVID-19 cases managed in intensive care units (ICU). Supportive lung-protective ventilation and prone positioning remain the mainstay interventions. Purpose: We describe the severity of ARDS, clinical outcomes, and management of ICU patients with laboratory-confirmed COVID-19 infection in multiple Saudi hospitals. Methods: A multicenter retrospective cohort study was conducted of critically ill patients who were admitted to the ICU with COVID-19 and developed ARDS. Results: During our study, 1154 patients experienced ARDS: 591 (51.2%) with severe, 415 (36.0%) with moderate, and 148 (12.8%) with mild ARDS. The mean sequential organ failure assessment (SOFA) score was significantly higher in severe ARDS with COVID-19 (6 ± 5, p = 0.006). Kaplan–Meier survival analysis showed COVID-19 patients with mild ARDS had a significantly higher survival rate compared to COVID-19 patients who experienced severe ARDS (p = 0.023). Conclusion: ARDS is a challenging condition complicating COVID-19 infection. It carries significant morbidity and results in elevated mortality. ARDS requires protective mechanical ventilation and other critical care supportive measures. The severity of ARDS is associated significantly with the rate of death among the patients.
Open AccessClinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
Background: Acute Respiratory Distress Syndrome (ARDS) is caused by non-cardiogenic pulmonary edema and occurs in critically ill patients. It is one of the fatal complications observed among severe COVID-19 cases managed in intensive care units (ICU). Supportive lung-protective ventilation and prone positioning remain the mainstay interventions. Purpose: We describe the severity of ARDS, clinical outcomes, and management of ICU patients with laboratory-confirmed COVID-19 infection in multiple Saudi hospitals. Methods: A multicenter retrospective cohort study was conducted of critically ill patients who were admitted to the ICU with COVID-19 and developed ARDS. Results: During our study, 1154 patients experienced ARDS: 591 (51.2%) with severe, 415 (36.0%) with moderate, and 148 (12.8%) with mild ARDS. The mean sequential organ failure assessment (SOFA) score was significantly higher in severe ARDS with COVID-19 (6 ± 5, p = 0.006). Kaplan–Meier survival analysis showed COVID-19 patients with mild ARDS had a significantly higher survival rate compared to COVID-19 patients who experienced severe ARDS (p = 0.023). Conclusion: ARDS is a challenging condition complicating COVID-19 infection. It carries significant morbidity and results in elevated mortality. ARDS requires protective mechanical ventilation and other critical care supportive measures. The severity of ARDS is associated significantly with the rate of death among the patients.
- 1 January 2018
- Published by A and V Publications in Asian Journal of Research in Pharmaceutical Sciences
- Vol. 8 (3) , 170-176
The Practice of Counseling in Pharmacy: Patients’ Perspectives
Aim The objective of the study was to assess pharmacists’ counseling practices from the patient perspective usingthe United States Pharmacopeia (USP) Medication Counseling Behavior Guidelines (MCBG) questionnaire. Methods Thiswas a cross-sectional study conducted over4 monthsin the outpatients section of the pharmacy department in two tertiary care hospitals: King Abdulaziz Medical City, Riyadh, and King Fahad Medical City. Participants were randomly selected to complete the USP-MCBG questionnaire, and gave their full consent to the data collector. USP-MCBG questionnaire is an interactive approach between the patient and the pharmacist, which takes into account the patient's special needs, beliefs and perceptions about medication use. The questionnaire included 33items with a two-point response scale. The questionnaire was divided into four sections corresponding to the four stages of the medication counseling process. Results During thestudy period, 520subjects wereenrolled and of these, 486 responded to our questionnaire (response rate: 93%). The study population was gender balanced; most respondents (88%) were Saudi nationals, and 49% reportedhaving at least high school education. There were no differences between the socio-demographic profiles of participants at the two study sites. The overall mean USP-MCBG score of satisfaction was 3.18 ±0.11 (highest score is 5). Within subsections of the questionnaire, ‘Management oftreatment’ scored the highest (1.14±0.05) and ‘Communication’ scored the lowest (0.35±0.03).In terms of medication counseling, more than >80% of patientshad a positive perception and were satisfied with the performance of outpatientpharmacists. At almost all stages of the counseling process, there was a slightly inverselyproportional relationship between patient age and satisfaction with pharmacist performance. Conclusion Using the USP-MCB guidelines, patients’ perceptionof and satisfaction with pharmacists counseling in the outpatient setting was positive. Greater effort is needed to ensure effective counseling services in particular subpopulations, such as in the elderly. In general, patients were more satisfied with pharmacist counseling pertinent to “management of treatment”, however, they were less satisfied regarding the pharmacists ’way of communication
- 1 January 2018
- Published by A and V Publications in Asian Journal of Research in Pharmaceutical Sciences
- Vol. 8 (3) , 170-176
The Practice of Counseling in Pharmacy: Patients’ Perspectives
Aim The objective of the study was to assess pharmacists’ counseling practices from the patient perspective usingthe United States Pharmacopeia (USP) Medication Counseling Behavior Guidelines (MCBG) questionnaire. Methods Thiswas a cross-sectional study conducted over4 monthsin the outpatients section of the pharmacy department in two tertiary care hospitals: King Abdulaziz Medical City, Riyadh, and King Fahad Medical City. Participants were randomly selected to complete the USP-MCBG questionnaire, and gave their full consent to the data collector. USP-MCBG questionnaire is an interactive approach between the patient and the pharmacist, which takes into account the patient's special needs, beliefs and perceptions about medication use. The questionnaire included 33items with a two-point response scale. The questionnaire was divided into four sections corresponding to the four stages of the medication counseling process. Results During thestudy period, 520subjects wereenrolled and of these, 486 responded to our questionnaire (response rate: 93%). The study population was gender balanced; most respondents (88%) were Saudi nationals, and 49% reportedhaving at least high school education. There were no differences between the socio-demographic profiles of participants at the two study sites. The overall mean USP-MCBG score of satisfaction was 3.18 ±0.11 (highest score is 5). Within subsections of the questionnaire, ‘Management oftreatment’ scored the highest (1.14±0.05) and ‘Communication’ scored the lowest (0.35±0.03).In terms of medication counseling, more than >80% of patientshad a positive perception and were satisfied with the performance of outpatientpharmacists. At almost all stages of the counseling process, there was a slightly inverselyproportional relationship between patient age and satisfaction with pharmacist performance. Conclusion Using the USP-MCB guidelines, patients’ perceptionof and satisfaction with pharmacists counseling in the outpatient setting was positive. Greater effort is needed to ensure effective counseling services in particular subpopulations, such as in the elderly. In general, patients were more satisfied with pharmacist counseling pertinent to “management of treatment”, however, they were less satisfied regarding the pharmacists ’way of communication